Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
N-sulfonylpyrimidine derivatives exhibited antitumor activity in breast cancer
January 19th, 2006
Scientists suggested N-sulfonylpyrimidine derivatives exhibited antitumor activity in mouse breast cancer cells. According to recent research published in the Journal of Cancer Research and Clinical Oncology, "The purpose of this study was to investigate in vivo antitumor activity of newly synthesized N-sulfonylpyrimidine derivatives 1-(p-toluenesulfonyl)cytosine (4H), 1-(p-toluenesulfonyl)cytosine hydrochloride (4HxHCl) and zinc(II) complex of 1-(p-toluenesulfonyl)cytosine (4K). In order to do that we have used mouse anaplastic mammary carcinoma (AMCa). Tumor cells (106) in a volume of .02 ml were transplanted into the thigh of the right hind leg of...
Source: Women's Health Weekly (2006-01-19)
|
